Aug 13, 2020
Global Market and Forecast Model for Hepatitis C Tests Market 2020 with Coverage of 39 Countries
Aug 13, 2020
Global Hepatitis B Tests Industry 2015-2030: COVID-19 Impact, Revenues by Segment, Total Procedures, Units, ASPs, and Market Values by Segment
Aug 12, 2020
Akero Therapeutics Reports Second Quarter 2020 Financial Results
Jun 17, 2020
ASC40 (TVB-2640) Significantly Reduced Liver Fat With a 61% Responder Rate in Phase 2 NASH Trial
Jun 17, 2020
Akero Therapeutics Doses First Patient in Expansion of Phase 2a Trial in NASH
Jun 17, 2020
Ascentage Pharma Announces First Patient Dosed in the Phase II Clinical Study of IAP Antagonist APG-1387 in Combination with Entecavir for the Treatment of Patients with Chronic Hepatitis B
Jun 15, 2020
Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral Insulin
Jun 10, 2020
MYR Pharmaceuticals has incorporated its first European subsidiary in France
May 29, 2020
MYR Pharmaceuticals receives positive CHMP opinion for HEPCLUDEX® (bulevirtide), the First-in-Class Entry Inhibitor for the treatment of chronic hepatitis D infections
May 28, 2020
DURECT to Present at the Jefferies 2020 Virtual Health Care Conference
May 26, 2020
Akero Therapeutics To Present At The Jefferies Virtual Healthcare Conference
May 24, 2020
HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China
May 13, 2020
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication
May 11, 2020
DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs
Mar 31, 2020
All AKR-001 Dose Groups Met Week 12 Efficacy Endpoints in NASH Phase 2a BALANCED Study
Mar 31, 2020
Data on Sagimet's Lead Candidate TVB-2640 to be Presented at EASL ILC 2020
Mar 31, 2020
Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020
Mar 24, 2020
Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patients
Mar 23, 2020
Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis
Mar 16, 2020
Akero Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results